About this Journal Submit a Manuscript Table of Contents
Journal of Obesity
Volume 2011 (2011), Article ID 394658, 8 pages
http://dx.doi.org/10.1155/2011/394658
Clinical Study

Impact of Orlistat-Induced Weight Loss on Diastolic Function and Heart Rate Variability in Severely Obese Subjects with Diabetes

Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), 2725 Chemin Ste-Foy, QC, Canada G1V 4G5

Received 20 May 2010; Accepted 21 November 2010

Academic Editor: Luc F. Van Gaal

Copyright © 2011 Julie Martin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Poirier, T. D. Giles, G. A. Bray et al., “Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism,” Circulation, vol. 113, no. 6, pp. 898–918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. R. Peterson, M. Rothschild, C. R. Weinberg, R. D. Fell, K. R. McLeish, and M. A. Pfeifer, “Body fat and the activity of the autonomic nervous sytem,” New England Journal of Medicine, vol. 318, no. 17, pp. 1077–1083, 1988. View at Scopus
  3. J. Hirsch, R. L. Leibel, R. Mackintosh, and A. Aguirre, “Heart rate variability as a measure of autonomic function during weight change in humans,” American Journal of Physiology, vol. 261, no. 6, part 2, pp. R1418–R1423, 1991. View at Scopus
  4. K. Karason, H. Mølgaard, J. Wikstrand, and L. Sjöström, “Heart rate variability in obesity and the effect of weight loss,” American Journal of Cardiology, vol. 83, no. 8, pp. 1242–1247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Bobbioni-Harsch, J. Sztajzel, V. Barthassat et al., “The effect of insulin on cardiac autonomic balance predicts weight reduction after gastric bypass,” Diabetologia, vol. 48, no. 7, pp. 1258–1263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Akehi, H. Yoshimatsu, M. Kurokawa et al., “VLCD-induced weight loss improves heart rate variability in moderately obese Japanese,” Experimental Biology and Medicine, vol. 226, no. 5, pp. 440–445, 2001. View at Scopus
  7. P. Poirier, T. L. Hernandez, K. M. Weil, T. J. Shepard, and R. H. Eckel, “Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity,” Obesity Research, vol. 11, no. 9, pp. 1040–1047, 2003. View at Scopus
  8. M. Facchini, G. Malfatto, L. Sala et al., “Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients,” Journal of Endocrinological Investigation, vol. 26, no. 2, pp. 138–142, 2003. View at Scopus
  9. P. Rissanen, A. Franssila-Kallunki, and A. Rissanen, “Cardiac parasympathetic activity is increased by weight loss in healthy obese women,” Obesity Research, vol. 9, no. 10, pp. 637–643, 2001. View at Scopus
  10. M. A. Alpert, C. R. Lambert, H. Panayiotou et al., “Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss,” American Journal of Cardiology, vol. 76, no. 16, pp. 1194–1197, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Backman, U. Freyschuss, D. Hallberg, and A. Melcher, “Reversibility of cardiovascular changes in extreme obesity. Effects of weight reduction through jejunoileostomy,” Acta Medica Scandinavica, vol. 205, no. 5, pp. 367–373, 1979. View at Scopus
  12. M. A. Alpert, C. R. Lambert, B. E. Terry et al., “Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients,” American Journal of Cardiology, vol. 73, no. 12, pp. 918–921, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Willens, S. C. Chakko, P. Byers et al., “Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue doppler imaging,” American Journal of Cardiology, vol. 95, no. 12, pp. 1521–1524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. O. J. Rider, J. M. Francis, M. K. Ali et al., “Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity,” Journal of the American College of Cardiology, vol. 54, no. 8, pp. 718–726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Klein, L. E. Burke, G. A. Bray et al., “Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism,” Circulation, vol. 110, no. 18, pp. 2952–2967, 2004. View at Publisher · View at Google Scholar
  16. “Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health,” Obesity Research, vol. 6, supplement 2, pp. 51S–209S, 1998.
  17. N. Finer, W. P. T. James, P. G. Kopelman, M. E. J. Lean, and G. Williams, “One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor,” International Journal of Obesity, vol. 24, no. 3, pp. 306–313, 2000.
  18. M. T. La Rovere, G. D. Pinna, R. Maestri et al., “Short-term heart rate variability strongly predicts sudden cadiac death in chronic heart failure patients,” Circulation, vol. 107, no. 4, pp. 565–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Redfield, S. J. Jacobsen, J. C. Burnett, D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer, “Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic,” Journal of the American Medical Association, vol. 289, no. 2, pp. 194–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Poirier, P. Bogaty, C. Garneau, L. Marois, and J. G. Dumesnil, “Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy,” Diabetes Care, vol. 24, no. 1, pp. 5–10, 2001. View at Scopus
  21. P. Poirier, P. Bogaty, F. Philippon, C. Garneau, C. Fortin, and J. G. Dumesnil, “Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes,” Metabolism, vol. 52, no. 8, pp. 1056–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Scopus
  23. “Guidelines from the Canadian Cardiovascular Society and the Canadian Hypertension Society on the echocardiographic determination of left ventricular mass. Task Force of the Echocardiography Section,” The Canadian Journal of Cardiology, vol. 11, no. 5, pp. 391–395, 1995.
  24. D. Levy, D. D. Savage, and R. J. Garrison, “Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study,” American Journal of Cardiology, vol. 59, no. 9, pp. 956–960, 1987. View at Scopus
  25. “Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology,” European Heart Journal, vol. 17, no. 3, pp. 354–381, 1996.
  26. R. R. Jhaveri, K. K. Pond, T. H. Hauser et al., “Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery,” Surgery for Obesity and Related Diseases, vol. 5, no. 6, pp. 648–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chakko, M. Mayor, M. D. Allison, K. M. Kessler, B. J. Materson, and R. J. Myerburg, “Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity,” American Journal of Cardiology, vol. 68, no. 1, pp. 95–98, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Kanoupakis, D. Michaloudis, O. Fraidakis, F. Parthenakis, P. Vardas, and J. Melissas, “Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity,” Obesity Surgery, vol. 11, no. 5, pp. 552–558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Alaud-din, S. Meterissian, R. Lisbona, L. D. MacLean, and R. A. Forse, “Assessment of cardiac function in patients who were morbidly obese,” Surgery, vol. 108, no. 4, pp. 809–818, 1990. View at Scopus
  30. D. H. Ryan, W. D. Johnson, V. H. Myers et al., “Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study,” Archives of Internal Medicine, vol. 170, no. 2, pp. 146–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. G. Martínez, F. A. Ruiz, and S. D. Candil, “Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme,” British Journal of Nutrition, vol. 96, no. 5, pp. 956–964, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. G. De Simone, C. Romano, C. De Caprio et al., “Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 1, pp. 24–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Sjöström, A. Rissanen, T. Andersen et al., “Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients,” Lancet, vol. 352, no. 9123, pp. 167–172, 1998. View at Publisher · View at Google Scholar
  34. J. Hauptman, C. Lucas, M. N. Boldrin, H. Collins, and K. R. Segal, “Orlistat in the long-term treatment of obesity in primary care settings,” Archives of Family Medicine, vol. 9, no. 2, pp. 160–167, 2000. View at Scopus
  35. M. H. Davidson, J. Hauptman, M. DiGirolamo et al., “Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial,” Journal of the American Medical Association, vol. 281, no. 3, pp. 235–242, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Lindgarde, “The effect of orlistat body weight and coronary heart disease risk profile in obese patients: the swedish multimorbidity study,” Journal of Internal Medicine, vol. 248, no. 3, pp. 245–254, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. J. H. Zavoral, “Treatment with orlistat reduces cardiovascular risk in obese patients,” Journal of Hypertension, vol. 16, no. 12, part 2, pp. 2013–2017, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. P. A. Hollander, S. C. Elbein, I. B. Hirsch et al., “Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study,” Diabetes Care, vol. 21, no. 8, pp. 1288–1294, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. D. E. Kelley, L. H. Kuller, T. M. McKolanis, P. Harper, J. Mancino, and S. Kalhan, “Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes,” Diabetes Care, vol. 27, no. 1, pp. 33–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Fujioka, T. B. Seaton, E. Rowe et al., “Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus,” Diabetes, Obesity and Metabolism, vol. 2, no. 3, pp. 175–187, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. J. G. Dumesnil, C. Paulin, P. Pibarot, D. Coulombe, and M. Arsenault, “Mitral annulus velocities by Doppler tissue imaging: practical implications with regard to preload alterations, sample position, and normal values,” Journal of the American Society of Echocardiography, vol. 15, no. 10, part 2, pp. 1226–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus